Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$30.53 - $41.09 $763,250 - $1.03 Million
-25,000 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$33.62 - $61.93 $16,810 - $30,965
-500 Reduced 1.96%
25,000 $1.55 Million
Q3 2020

Nov 05, 2020

BUY
$22.23 - $37.48 $17,784 - $29,983
800 Added 3.24%
25,500 $854,000
Q2 2020

Aug 12, 2020

BUY
$20.26 - $29.73 $207,259 - $304,137
10,230 Added 70.7%
24,700 $589,000
Q4 2019

Jan 27, 2020

BUY
$20.01 - $30.79 $289,544 - $445,531
14,470 New
14,470 $410,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $386M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.